RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CICCARESE C
Collezione AOU San Luigi di Orbassano

Items : 10

Adjuvant pembrolizumab prolongs overall survival in renal cell carcinoma at high-risk of recurrence after nephrectomy. Can we do better than this? in Minerva urology and nephrology / Minerva Urol Nephrol. 2024 Oct;76(5):540-544. doi: 10.23736/S2724-6051.24.06114-7.

2024
AOU San Luigi di Orbassano
AOU Novara

Amparore D; Palumbo C; Campi R; Marandino L; Mollica V; Ciccarese C;

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study. in European urology / Eur Urol. 2024 Nov;86(5):411-419. doi: 10.1016/j.eururo.2024.02.014. Epub 2024 Mar 22.

2024
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Buti S; Zucali PA; Fantinel E; Bimbatti D; Verzoni E; Accettura C; Bonomi L; Buttigliero C; Fornarini G; Pipitone S; Atzori F; Masini C; Massari F; Primi F; Strusi A; Giudice GC; Perrino M; Maruzzo M; Milella M; Giannarelli D; Brunelli M; Procopio G; Tortora G;

The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data. in Urologic oncology / Urol Oncol. 2024 May;42(5):163.e1-163.e13. doi: 10.1016/j.urolonc.2024.01.028. Epub 2024 Mar 5.

2024
AOU San Luigi di Orbassano
AOU Novara

Simone G; Rebez G; Schips L; Degirmenci E; Aydin R; Ciccarese C; Wu Z; Calio A; Warren H; Palumbo C; Borregales L; Diana P; Marandino L; Muselaers S; Pecoraro A; Klatte T; Marchioni M; Kara O; Carbonara U; Pavan N; Roussel E; Anceschi U; Mir MC; Amparore D; Capitanio U; Campi R; Bertolo R; Erdem S; Minervini A; et alii...

Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy. in European urology oncology / Eur Urol Oncol. 2024 Feb;7(1):112-121. doi: 10.1016/j.euo.2023.06.006. Epub 2023 Jul 18.

2024
AOU San Luigi di Orbassano
AOU Novara

Wang L; Qu L; Chen C; Li M; Feng X; Ge J; Zheng J; Wang S; Zhou X; Shi B; Xue W; Wang Z; Qin W; Chen M; Guo H; Zu X; Jiang J; Xia D; Liu Z; Wang G; Liang C; Xu N; Wang J; Rao Q; Miao H; Cheng J; Wang F; Gao J; Wang H; et alii...

Metastatic de-novo renal cell carcinoma in the era of immune combinations: what can we learn from real-world data? in Minerva urology and nephrology / Minerva Urol Nephrol. 2024 Feb;76(1):120-123. doi: 10.23736/S2724-6051.23.05640-9.

2024
AOU San Luigi di Orbassano

Francolini G; Marandino L; Ciccarese C; Pecoraro A; Amparore D; Campi R;

YAU renal cancer spotlight: how should cost-effectiveness affect decision-making regarding adjuvant pembrolizumab for clear cell renal cell carcinoma? in Minerva urology and nephrology / Minerva Urol Nephrol. 2024 Dec;76(6):797-801. doi: 10.23736/S2724-6051.24.06268-2.

2024
AOU San Luigi di Orbassano

Erdem S; Marandino L; Roussel E; Ciccarese C; Amparore D; Campi R;

The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Apr;75(2):260-264. doi: 10.23736/S2724-6051.23.05327-2.

2023
AOU San Luigi di Orbassano

Marandino L; Ciccarese C; Francolini G; Amparore D; Campi R;

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2.

2022
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Brunelli M; Battelli N; Buttigliero C; Caserta C; Buti S; Santini D; Carella C; Galli L; Verri E; Ermacora P; Merler S; Masini C; De Vivo R; Milesi L; Spina F; Rizzo M; Sperduti I; Fornarini G; Tortora G;

Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis. in Journal of clinical medicine / J Clin Med. 2020 May 5;9(5):1351. doi: 10.3390/jcm9051351.

2020
AOU San Luigi di Orbassano

Lamberti G; Brizzi MP; Pusceddu S; Gelsomino F; Di Meglio G; Massari F; Badalamenti G; Riccardi F; Ibrahim T; Ciccarese C; Buti S; Carnaghi C; Prinzi N; Panzuto F; Campana D;

De novo metastatic castration sensitive prostate cancer: State of art and future perspectives. in Cancer treatment reviews / Cancer Treat Rev. 2018 Nov;70:67-74. doi: 10.1016/j.ctrv.2018.08.005. Epub 2018 Aug 11.

2018
AOU San Luigi di Orbassano

Mosillo C; Iacovelli R; Ciccarese C; Fantinel E; Bimbatti D; Brunelli M; Bisogno I; Kinspergher S; Buttigliero C; Tucci M; Caffo O; Tortora G;